MoneyWorks4Me

Strides Pharma Scien - Quaterly Results

29 Jul 2022 Evaluate
The sales is pegged at Rs. 4231.90 millions for the June 2022 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 5087.90 millions during the year-ago period.The Net Loss for the quarter ended June 2022 is Rs. -662.54 millions as compared to Net Loss of Rs. -212.31 millions of corresponding quarter ended June 2021Operating profit Margin for the quarter ended June 2022 slipped to -535.67% as compared to 169.36% of corresponding quarter ended June 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 4231.90 5087.90 -16.82 4231.90 5087.90 -16.82 19790.03 18575.66 6.54
Other Income 74.65 116.86 -36.12 74.65 116.86 -36.12 1234.85 889.96 38.75
PBIDT -535.67 169.36 -416.29 -535.67 169.36 -416.29 2001.15 2763.16 -27.58
Interest 260.17 180.91 43.81 260.17 180.91 43.81 742.41 653.39 13.62
PBDT -795.84 -11.55 6790.39 -795.84 -11.55 6790.39 1258.74 2109.77 -40.34
Depreciation 242.96 266.36 -8.79 242.96 266.36 -8.79 1043.66 993.42 5.06
PBT -1038.80 -277.91 273.79 -1038.80 -277.91 273.79 215.08 1116.35 -80.73
TAX -376.26 -65.60 473.57 -376.26 -65.60 473.57 -1586.80 333.95 -575.16
Deferred Tax -376.26 -65.60 473.57 -376.26 -65.60 473.57 -2.09 123.77 -101.69
PAT -662.54 -212.31 212.06 -662.54 -212.31 212.06 1801.88 782.40 130.30
Equity 898.04 897.17 0.10 898.04 897.17 0.10 897.90 896.80 0.12
PBIDTM(%) -12.66 3.33 -480.27 -12.66 3.33 -480.27 10.11 14.88 -32.02
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..